These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9551143)

  • 1. The regulation and function of the p53 tumor suppressor.
    Mansur CP
    Adv Dermatol; 1997; 13():121-66. PubMed ID: 9551143
    [No Abstract]   [Full Text] [Related]  

  • 2. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].
    Hainaut P
    Bull Cancer; 2000 Jan; 87(1):11-8. PubMed ID: 10673626
    [No Abstract]   [Full Text] [Related]  

  • 4. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular bases of the programmed cell death process: implications of tumor suppressor protein p53 and other proteins in the control of cell cycle. Mechanisms of apoptotic action. Review].
    Merino JJ; Cordero-Campaña MI
    Invest Clin; 1998 Dec; 39(4):323-58. PubMed ID: 9927805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA; Cerbón MA
    Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild type p53 gene causes reorganization of cytoskeleton and, therefore, the impaired deformability and difficult migration of murine erythroleukemia cells.
    Yao W; Gu L; Sun D; Ka W; Wen Z; Chien S
    Cell Motil Cytoskeleton; 2003 Sep; 56(1):1-12. PubMed ID: 12905527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1.
    Huang SM; Schönthal AH; Stallcup MR
    Oncogene; 2001 Apr; 20(17):2134-43. PubMed ID: 11360197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative gene expression profiling in response to p53 in a human lung cancer cell line.
    Song S; MacLachlan TK; Meng RD; El-Deiry WS
    Biochem Biophys Res Commun; 1999 Nov; 264(3):891-5. PubMed ID: 10544026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
    Olive KP; Tuveson DA; Ruhe ZC; Yin B; Willis NA; Bronson RT; Crowley D; Jacks T
    Cell; 2004 Dec; 119(6):847-60. PubMed ID: 15607980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of p53 by Pitx1.
    Liu DX; Lobie PE
    Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cell cycle regulation by anti-oncogene].
    Akiyama T
    Tanpakushitsu Kakusan Koso; 1994 Sep; 39(12):2158-62. PubMed ID: 7938611
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of p53 and p16 gene alterations in determining response to concurrent paclitaxel and radiation in solid tumor.
    King TC; Estalilla OC; Safran H
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):4-11. PubMed ID: 10210535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of efficient apoptosis and cell-cycle arrest in tumor cells by adenovirus-mediated p53 A4 mutant.
    Maeda A; Nakamura S; Isono M; Osaki M; Ito H; Sato K
    Pathol Int; 2006 Mar; 56(3):126-34. PubMed ID: 16497245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
    Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
    Wiman KG
    Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.